A synthetic nonapeptide (Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro) which is identical to the peptide from the venom of the snake, Bothrops jararaca. It inhibits kininase II and ANGIOTENSIN I and has been proposed as an antihypertensive agent.
Also Known As:
BPP-9a; Bradykinin-Potentiating Peptide 9a; Nonapeptide-Converting Enzyme Inhibitor; SQ-20881; Bradykinin Potentiating Peptide 9a; Enzyme Inhibitor, Nonapeptide-Converting; Nonapeptide Converting Enzyme Inhibitor; Peptide 9a, Bradykinin-Potentiating; Bradykinin potentiator B, 2-L-tryptophan-3-de-L-leucine-4-de-L-proline-8-L-glutamine-
Networked: 34 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1. Hypertension (High Blood Pressure)
2. Heart Failure
3. Body Weight (Weight, Body)
4. Renovascular Hypertension (Goldblatt Syndrome)
5. Syncope (Fainting)

Related Drugs and Biologics

1. Captopril (Capoten)
2. Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
3. Renin
4. Angiotensin II
5. Sodium
6. Saralasin (Saralasin Acetate)
7. Enzyme Inhibitors
8. Enalapril
9. renin inhibitory peptide
10. Angiotensins

Related Therapies and Procedures

1. Transplants (Transplant)
2. Nephrectomy
3. Sodium-Restricted Diet (Diet, Sodium Restricted)
4. Aftercare (After-Treatment)